Research on nano-DDS imaging
We are aiming for the establishment of "visible nanodevice" that contains multiple imaging agents such as PET/SPECT and MRI. With the imaging device having high sensitivity, quantitative ability, and spatial resolution, we can detect cancer at its very early stage. In addition, the imaging of the DDS process enables prediction and early evaluation of treatment effect. We label micelle-type nanodevice with positron emitter (Cu-64, etc.), ganma-ray emitter (In-111, etc.) and MRI contrast agents (Gd, Mn, etc.), and evaluate/optimize the biodistibution for the realization of high-quality multi-modal imaging of cancer.
|Affiliation||Diagnostic Imaging Program,
Molecular Imaging Center,
National Institute of Radiological Sciences
|Specialty||Molecular Imaging Oncological Nuclear Medicine|
|Address||4-9-1 Anagawa, Inage-ku, Chiba 263-8555 Japan|